Table 1.
Sample characteristics.
| Controls (N = 40) | Patients (N = 149) | Overall (N = 189) | |
|---|---|---|---|
| Age | |||
| Mean (SD) | 14.8 (1.28) | 14.9 (1.48) | 14.9 (1.44) |
| Median [Min, Max] | 15.0 [12.0, 17.0] | 15.0 [12.0, 19.0] | 15.0 [12.0, 19.0] |
| Psychoactive medication | |||
| Yes | 0 (0%) | 13 (8.7%) | 13 (6.9%) |
| No | 40 (100%) | 136 (91.3%) | 176 (93.1%) |
| Drug consumption | |||
| Yes | 7 (17.5%) | 44 (29.5%) | 51 (27.0%) |
| No | 33 (82.5%) | 105 (70.5%) | 138 (73.0%) |
| Smoking | |||
| Yes | 9 (22.5%) | 76 (51.0%) | 85 (45.0%) |
| No | 31 (77.5%) | 73 (49.0%) | 104 (55.0%) |
| fT3 [ng/l] | |||
| Mean (SD) | 3.55 (0.451) | 3.40 (0.378) | 3.43 (0.398) |
| Median [Min, Max] | 3.50 [2.59, 4.40] | 3.38 [2.35, 4.67] | 3.38 [2.35, 4.67] |
| Leukocytes [/nl] | |||
| Mean (SD) | 5.63 (1.49) | 6.63 (1.87) | 6.42 (1.84) |
| Median [Min, Max] | 5.38 [3.14, 9.31] | 6.33 [3.43, 14.5] | 6.17 [3.14, 14.5] |
| DHEA-S [µg/ml] | |||
| Mean (SD) | 6.78 (31.2) | 1.96 (1.07) | 2.98 (14.4) |
| Median [Min, Max] | 1.66 [0.600, 199] | 1.68 [0.390, 5.79] | 1.68 [0.390, 199] |
| Oxytocin [µg/ml] | |||
| Mean (SD) | 211 (131) | 135 (147) | 151 (147) |
| Median [Min, Max] | 181 [64.3, 795] | 106 [40.4, 1540] | 131 [40.4, 1540] |
| Beta-endorphin [µg/ml] | |||
| Mean (SD) | 38.4 (20.1) | 34.4 (28.2) | 35.3 (26.7) |
| Median [Min, Max] | 39.2 [2.40, 94.3] | 26.0 [0.400, 224] | 28.6 [0.400, 224] |
| Pain threshold [C°] | |||
| Mean (SD) | 41.7 (3.28) | 42.7 (3.80) | 42.5 (3.71) |
| Median [Min, Max] | 42.0 [34.3, 46.9] | 43.5 [34.1, 50.0] | 43.0 [34.1, 50.0] |
| vmHRV | |||
| Mean (SD) | 58.4 (28.6) | 54.9 (28.6) | 55.6 (28.5) |
| Median [Min, Max] | 51.3 [21.4, 132] | 48.1 [13.6, 178] | 49.1 [13.6, 178] |
| No. days with NSSI events past year | |||
| Mean (SD) | 0 (0) | 56.9 (66.9) | 44.7 (63.7) |
| Median [Min, Max] | 0 [0, 0] | 30.0 [1.00, 350] | 18.0 [0, 350] |
| No. of fulfilled criteria for BPD | |||
| Mean (SD) | 0.0750 (0.350) | 3.24 (2.09) | 2.57 (2.27) |
| Median [Min, Max] | 0 [0, 2.00] | 3.00 [0, 8.00] | 2.00 [0, 8.00] |
| Depression severity (DIKJ raw score) | |||
| Mean (SD) | 6.33 (5.23) | 29.3 (9.04) | 24.0 (12.8) |
| Median [Min, Max] | 5.00 [0, 29.0] | 30.0 [7.00, 47.0] | 28.0 [0, 47.0] |
| Missing | 1 (2.5%) | 19 (12.8%) | 20 (10.6%) |
| Diagnosesa | |||
| F10-F19, n (%) | – | 24 (16.1) | |
| F30-F39, n (%) | – | 92 (61.7) | |
| F40-F48, n (%) | – | 65 (43.6) | |
| F50-F59, n (%) | – | 19 (12.8) | |
| F60-F69, n (%) | – | 54 (36.2) | |
| F80-F89, n (%) | – | 1 (0.7) | |
| F90-F98, n (%) | – | 32 (21.5) |
SD standard deviation, Smoking: on more than one day in the last year. Drug consumption: at least one day of drug consumption during the last year. fT3 free triiodothyronine, DHEA dehydroepiandrosterone, vmHRV vagally mediated heart rate variability, NSSI non-suicidal self-injury, BPD borderline personality disorder, DIKJ Depressionsinventar für Kinder und Jugendliche.
ano F0, F2, or F7 disorders were diagnosed.